Page last updated: 2024-12-08

actinonin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

actinonin: natural hydroxamic acid, pseudopeptide antibiotic isolated from Streptomyces species; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID443600
CHEMBL ID308333
SCHEMBL ID279450
MeSH IDM0056088

Synonyms (69)

Synonym
CHEMBL308333 ,
n*4*-hydroxy-n*1*-[1-(2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl]-2-pentyl-succinamide
BRD-K24621118-001-02-5
DIVK1C_001024
KBIO1_001024
EU-0100010
butanediamide, n4-hydroxy-n1-(1-((2-(hydroxymethyl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)-2-pentyl-, stereoisomer
SPECTRUM4_001932
LOPAC0_000010
SPECTRUM5_000728
IDI1_001024
octanohydroxamic acid, 3-((1-((2-(hydroxymethyl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamoyl)-
actinonine
(2r)-2-[2-(hydroxyamino)-2-oxo-ethyl]-n-[(1s)-1-[(2s)-2-(hydroxymethyl)pyrrolidine-1-carbonyl]-2-methyl-propyl]heptanamide
BB2 ,
actinonin
13434-13-4
DB04310
2-[(formyl-hydroxy-amino)-methyl]-heptanoic acid [1-(2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl]-amide
KBIOGR_002305
KBIO3_001599
SPECTRUM2_000628
SPECTRUM3_000680
SPBIO_000596
NINDS_001024
BSPBIO_002379
NCGC00093535-02
NCGC00093535-01
NCGC00093535-03
A 6671
NCGC00093535-04
n*4*-hydroxy-n*1*-[(s)-1-((s)-2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl]-2-(r)-pentyl-succinamide
(r)-n4-hydroxy-n1-((s)-1-((s)-2-(hydroxymethyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)-2-pentylsuccinamide
(r)-n*4*-hydroxy-n*1*-[(s)-1-((s)-2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl]-2-pentyl-succinamide
bdbm50089194
HMS503M09
(2r)-n'-hydroxy-n-[(2s)-1-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-2-pentylbutanediamide
HMS3260A21
CCG-38543
p18spa8n0k ,
unii-p18spa8n0k
LP00010
3G5K
4DR9
AKOS015894413
SCHEMBL279450
3M6R
3PN4
3M6P
3M6Q
(2r)-n4-hydroxy-n1-((2s)-1-((2s)-2-(hydroxymethyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)-2-pentylbutanediamide
tox21_500010
NCGC00260695-01
HB3737
4JE7
actinonin in combination with isoniazid and rifampicin
sr-01000075681
SR-01000075681-1
SR-01000075681-5
(2r)-n~4~-hydroxy-n~1~-[(1s)-1-{[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-2-methylpropyl]-2-pentylbutanediamide
Q4676979
CS-0064758
HY-113952
DTXSID70928580
(-)-actinonin
BRD-K24621118-001-03-3
SDCCGSBI-0049999.P004
NCGC00093535-07
F82262

Research Excerpts

Overview

Actinonin is a pseudotripeptide that displays a high affinity towards metalloproteases including peptide deformylases and M1 family aminopeptidases. It inhibits collagenase at micromolar concentrations.

ExcerptReferenceRelevance
"Actinonin is a pseudotripeptide that displays a high affinity towards metalloproteases including peptide deformylases (PDFs) and M1 family aminopeptidases. "( Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N.
Addlagatta, A; Arya, T; Bhukya, S; Ganji, RJ; Gumpena, R; Marapaka, AK; Reddi, R; Sankoju, P, 2015
)
2.08
"Actinonin is a pseudopeptide antibiotic which inhibits collagenase at micromolar concentrations [10]. "( [Inhibition of synovial collagenase by actinonin. Study of structure/activity relationship].
Boiziau, J; Bouboutou, R; Cartwright, T; Lelièvre, Y, 1989
)
1.99

Effects

ExcerptReferenceRelevance
"Actinonin which has been found to be an inhibitor of aminopeptidase M (EC 3.4.11.2) also inhibited enkephalinase A (EC 3.4.24.11) and enkephalin aminopeptidase which were partially purified from the corpus striatum membrane of guinea-pig brain. "( Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
Aoyagi, T; Hachisu, M; Hiranuma, T; Murata, S; Shibazaki, Y; Umezawa, H; Uotani, K, 1987
)
2.03

Actions

ExcerptReferenceRelevance
"Actinonin was found to inhibit all three enzymes of enkephalin metabolism and, when given peripherally, to potentiate enkephalin analgesia."( Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
Aoyagi, T; Hachisu, M; Hiranuma, T; Murata, S; Shibazaki, Y; Umezawa, H; Uotani, K, 1987
)
1.31

Treatment

Actinonin treatment 30 min before CLP reduced IL-1β levels and prevented the fall in renal capillary perfusion at 7 and 18 h. Treatment of cells led to a tumor-specific mitochondrial membrane depolarization and ATP depletion.

ExcerptReferenceRelevance
"Actinonin treatment 30 min before CLP reduced IL-1β levels and prevented the fall in renal capillary perfusion at 7 and 18 h."( Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis.
Gokden, N; Herzog, C; Kaushal, GP; Mayeux, PR; Wang, Z, 2011
)
2.53
"Actinonin treatment of cells led to a tumor-specific mitochondrial membrane depolarization and ATP depletion in a time- and dose-dependent manner; removal of actinonin led to a recovery of the membrane potential consistent with indirect effects on the electron transport chain."( Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.
Borella, CP; Bornmann, WG; Dy, BM; Gardner, JR; Hayes, PA; Heaney, ML; Lee, MD; Philips, MR; Scheinberg, DA; She, Y; Sirotnak, FM; Soskis, MJ, 2004
)
1.28

Bioavailability

ExcerptReferenceRelevance
" However, it has limited therapeutic application because of its low bioavailability and systemic toxicity if administered in free form."( Therapeutic potential of human serum albumin nanoparticles encapsulated actinonin in murine model of lung adenocarcinoma.
Ahlawat, P; Bal, A; Phutela, K; Sharma, S; Singh, N, 2022
)
0.95

Dosage Studied

ExcerptRelevanceReference
" Treatment of cells with a second inhibitor of polyamine biosynthesis, the S-adenosylmethionine decarboxylase (SAMDC) inhibitor SAM486A, also resulted in a dosage dependent decrease in meprin alpha and MMP-7 mRNA."( Inhibitors of polyamine biosynthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in hormone-independent human breast cancer cells.
Bond, JS; Manni, A; Matters, GL, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (32)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency0.00100.125919.1169125.8920AID2549
thioredoxin reductaseRattus norvegicus (Norway rat)Potency1.26850.100020.879379.4328AID588453
ATAD5 protein, partialHomo sapiens (human)Potency6.42870.004110.890331.5287AID493106; AID493107
GLS proteinHomo sapiens (human)Potency7.07950.35487.935539.8107AID624146
regulator of G-protein signaling 4Homo sapiens (human)Potency2.66540.531815.435837.6858AID504845
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency5.84310.001530.607315,848.9004AID1224819; AID1224820; AID1224821
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency9.46620.035520.977089.1251AID504332
peripheral myelin protein 22 isoform 1Homo sapiens (human)Potency84.921423.934123.934123.9341AID1967
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency2.23870.010039.53711,122.0200AID1479
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency100.00000.010323.856763.0957AID2662
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
lamin isoform A-delta10Homo sapiens (human)Potency14.12540.891312.067628.1838AID1487
neuropeptide S receptor isoform AHomo sapiens (human)Potency31.62280.015812.3113615.5000AID1461
Ataxin-2Homo sapiens (human)Potency39.81070.011912.222168.7989AID588378
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Peptide deformylase 1B, chloroplasticArabidopsis thaliana (thale cress)Ki0.14000.14000.14000.1400AID977610
Chain A, Peptide deformylase 1B, chloroplasticArabidopsis thaliana (thale cress)Ki0.14000.14000.14000.1400AID977610
Urokinase-type plasminogen activatorHomo sapiens (human)IC50 (µMol)0.14000.03703.385910.0000AID609144
Interstitial collagenaseHomo sapiens (human)IC50 (µMol)1.10000.00020.850210.0000AID109226
NeprilysinOryctolagus cuniculus (rabbit)IC50 (µMol)8.20000.00040.66118.2000AID147213
72 kDa type IV collagenaseHomo sapiens (human)IC50 (µMol)3.00000.00001.284810.0000AID107329
Stromelysin-1Homo sapiens (human)IC50 (µMol)6.00000.00001.148410.0000AID107671
NeprilysinHomo sapiens (human)IC50 (µMol)6.70000.00020.54226.7000AID147394
Angiotensin-converting enzyme Homo sapiens (human)IC50 (µMol)100.00000.00010.533610.0000AID38855
Aminopeptidase NHomo sapiens (human)IC50 (µMol)0.40000.40002.11003.9000AID1380363
Aminopeptidase NHomo sapiens (human)Ki230.05670.00081.956910.0000AID1096864; AID1096866; AID1380363
Peptide deformylaseStaphylococcus aureus subsp. aureus Mu50IC50 (µMol)0.00500.00500.00500.0050AID147706
Peptide deformylaseStaphylococcus aureusIC50 (µMol)0.02000.01200.02070.0300AID655294
Histone deacetylase 1Homo sapiens (human)IC50 (µMol)10.00000.00010.55439.9000AID1658889
Meprin A subunit betaHomo sapiens (human)Ki2.00000.02201.34072.0000AID1375470; AID1450126
Peptide deformylase 1A, chloroplastic/mitochondrialArabidopsis thaliana (thale cress)IC50 (µMol)0.02700.02700.02700.0270AID275202
Peptide deformylase, mitochondrialHomo sapiens (human)IC50 (µMol)0.56220.00150.37712.7000AID156922; AID157063; AID1658868; AID1658869; AID275201; AID609140
Peptide deformylase, mitochondrialHomo sapiens (human)Ki0.00030.00030.00030.0003AID157064
Peptide deformylase Escherichia coliIC50 (µMol)0.05200.00600.03500.1400AID157321; AID275203; AID609144
Histone deacetylase 6Homo sapiens (human)IC50 (µMol)10.00000.00000.53769.9000AID1658891
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (248)

Processvia Protein(s)Taxonomy
positive regulation of cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
response to hypoxiaUrokinase-type plasminogen activatorHomo sapiens (human)
proteolysisUrokinase-type plasminogen activatorHomo sapiens (human)
chemotaxisUrokinase-type plasminogen activatorHomo sapiens (human)
signal transductionUrokinase-type plasminogen activatorHomo sapiens (human)
blood coagulationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of signaling receptor activityUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesion mediated by integrinUrokinase-type plasminogen activatorHomo sapiens (human)
urokinase plasminogen activator signaling pathwayUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell population proliferationUrokinase-type plasminogen activatorHomo sapiens (human)
fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of wound healingUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
proteolysisInterstitial collagenaseHomo sapiens (human)
protein metabolic processInterstitial collagenaseHomo sapiens (human)
extracellular matrix disassemblyInterstitial collagenaseHomo sapiens (human)
collagen catabolic processInterstitial collagenaseHomo sapiens (human)
positive regulation of protein-containing complex assemblyInterstitial collagenaseHomo sapiens (human)
cellular response to UV-AInterstitial collagenaseHomo sapiens (human)
extracellular matrix organizationInterstitial collagenaseHomo sapiens (human)
angiogenesis72 kDa type IV collagenaseHomo sapiens (human)
ovarian follicle development72 kDa type IV collagenaseHomo sapiens (human)
ovulation from ovarian follicle72 kDa type IV collagenaseHomo sapiens (human)
luteinization72 kDa type IV collagenaseHomo sapiens (human)
blood vessel maturation72 kDa type IV collagenaseHomo sapiens (human)
intramembranous ossification72 kDa type IV collagenaseHomo sapiens (human)
proteolysis72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of cell adhesion72 kDa type IV collagenaseHomo sapiens (human)
heart development72 kDa type IV collagenaseHomo sapiens (human)
embryo implantation72 kDa type IV collagenaseHomo sapiens (human)
parturition72 kDa type IV collagenaseHomo sapiens (human)
response to xenobiotic stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to mechanical stimulus72 kDa type IV collagenaseHomo sapiens (human)
peripheral nervous system axon regeneration72 kDa type IV collagenaseHomo sapiens (human)
response to activity72 kDa type IV collagenaseHomo sapiens (human)
protein metabolic process72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix disassembly72 kDa type IV collagenaseHomo sapiens (human)
protein catabolic process72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of cell migration72 kDa type IV collagenaseHomo sapiens (human)
collagen catabolic process72 kDa type IV collagenaseHomo sapiens (human)
response to retinoic acid72 kDa type IV collagenaseHomo sapiens (human)
cellular response to reactive oxygen species72 kDa type IV collagenaseHomo sapiens (human)
response to nicotine72 kDa type IV collagenaseHomo sapiens (human)
endodermal cell differentiation72 kDa type IV collagenaseHomo sapiens (human)
response to hydrogen peroxide72 kDa type IV collagenaseHomo sapiens (human)
response to estrogen72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of vasoconstriction72 kDa type IV collagenaseHomo sapiens (human)
ephrin receptor signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
macrophage chemotaxis72 kDa type IV collagenaseHomo sapiens (human)
response to electrical stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to hyperoxia72 kDa type IV collagenaseHomo sapiens (human)
face morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
bone trabecula formation72 kDa type IV collagenaseHomo sapiens (human)
prostate gland epithelium morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
cellular response to amino acid stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to interleukin-172 kDa type IV collagenaseHomo sapiens (human)
cellular response to estradiol stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to UV-A72 kDa type IV collagenaseHomo sapiens (human)
cellular response to fluid shear stress72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
response to amyloid-beta72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix organization72 kDa type IV collagenaseHomo sapiens (human)
response to hypoxia72 kDa type IV collagenaseHomo sapiens (human)
tissue remodeling72 kDa type IV collagenaseHomo sapiens (human)
proteolysisStromelysin-1Homo sapiens (human)
extracellular matrix disassemblyStromelysin-1Homo sapiens (human)
protein catabolic processStromelysin-1Homo sapiens (human)
regulation of cell migrationStromelysin-1Homo sapiens (human)
collagen catabolic processStromelysin-1Homo sapiens (human)
positive regulation of protein-containing complex assemblyStromelysin-1Homo sapiens (human)
cellular response to reactive oxygen speciesStromelysin-1Homo sapiens (human)
innate immune responseStromelysin-1Homo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionStromelysin-1Homo sapiens (human)
cellular response to lipopolysaccharideStromelysin-1Homo sapiens (human)
cellular response to amino acid stimulusStromelysin-1Homo sapiens (human)
cellular response to UV-AStromelysin-1Homo sapiens (human)
cellular response to nitric oxideStromelysin-1Homo sapiens (human)
regulation of neuroinflammatory responseStromelysin-1Homo sapiens (human)
response to amyloid-betaStromelysin-1Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processStromelysin-1Homo sapiens (human)
extracellular matrix organizationStromelysin-1Homo sapiens (human)
kidney developmentNeprilysinHomo sapiens (human)
placenta developmentNeprilysinHomo sapiens (human)
proteolysisNeprilysinHomo sapiens (human)
peptide metabolic processNeprilysinHomo sapiens (human)
learning or memoryNeprilysinHomo sapiens (human)
substance P catabolic processNeprilysinHomo sapiens (human)
bradykinin catabolic processNeprilysinHomo sapiens (human)
sensory perception of painNeprilysinHomo sapiens (human)
protein catabolic processNeprilysinHomo sapiens (human)
lung developmentNeprilysinHomo sapiens (human)
hormone catabolic processNeprilysinHomo sapiens (human)
response to estrogenNeprilysinHomo sapiens (human)
creatinine metabolic processNeprilysinHomo sapiens (human)
amyloid-beta metabolic processNeprilysinHomo sapiens (human)
positive regulation of neurogenesisNeprilysinHomo sapiens (human)
neuropeptide processingNeprilysinHomo sapiens (human)
cellular response to cytokine stimulusNeprilysinHomo sapiens (human)
cellular response to UV-ANeprilysinHomo sapiens (human)
cellular response to UV-BNeprilysinHomo sapiens (human)
replicative senescenceNeprilysinHomo sapiens (human)
amyloid-beta clearanceNeprilysinHomo sapiens (human)
amyloid-beta clearance by cellular catabolic processNeprilysinHomo sapiens (human)
positive regulation of long-term synaptic potentiationNeprilysinHomo sapiens (human)
protein processingNeprilysinHomo sapiens (human)
response to hypoxiaAngiotensin-converting enzyme Homo sapiens (human)
kidney developmentAngiotensin-converting enzyme Homo sapiens (human)
blood vessel remodelingAngiotensin-converting enzyme Homo sapiens (human)
angiotensin maturationAngiotensin-converting enzyme Homo sapiens (human)
regulation of renal output by angiotensinAngiotensin-converting enzyme Homo sapiens (human)
neutrophil mediated immunityAngiotensin-converting enzyme Homo sapiens (human)
antigen processing and presentation of peptide antigen via MHC class IAngiotensin-converting enzyme Homo sapiens (human)
regulation of systemic arterial blood pressure by renin-angiotensinAngiotensin-converting enzyme Homo sapiens (human)
proteolysisAngiotensin-converting enzyme Homo sapiens (human)
spermatogenesisAngiotensin-converting enzyme Homo sapiens (human)
female pregnancyAngiotensin-converting enzyme Homo sapiens (human)
regulation of blood pressureAngiotensin-converting enzyme Homo sapiens (human)
male gonad developmentAngiotensin-converting enzyme Homo sapiens (human)
response to xenobiotic stimulusAngiotensin-converting enzyme Homo sapiens (human)
embryo development ending in birth or egg hatchingAngiotensin-converting enzyme Homo sapiens (human)
post-transcriptional regulation of gene expressionAngiotensin-converting enzyme Homo sapiens (human)
negative regulation of gene expressionAngiotensin-converting enzyme Homo sapiens (human)
substance P catabolic processAngiotensin-converting enzyme Homo sapiens (human)
bradykinin catabolic processAngiotensin-converting enzyme Homo sapiens (human)
regulation of smooth muscle cell migrationAngiotensin-converting enzyme Homo sapiens (human)
regulation of vasoconstrictionAngiotensin-converting enzyme Homo sapiens (human)
animal organ regenerationAngiotensin-converting enzyme Homo sapiens (human)
response to nutrient levelsAngiotensin-converting enzyme Homo sapiens (human)
response to lipopolysaccharideAngiotensin-converting enzyme Homo sapiens (human)
mononuclear cell proliferationAngiotensin-converting enzyme Homo sapiens (human)
response to laminar fluid shear stressAngiotensin-converting enzyme Homo sapiens (human)
angiotensin-activated signaling pathwayAngiotensin-converting enzyme Homo sapiens (human)
vasoconstrictionAngiotensin-converting enzyme Homo sapiens (human)
hormone metabolic processAngiotensin-converting enzyme Homo sapiens (human)
hormone catabolic processAngiotensin-converting enzyme Homo sapiens (human)
eating behaviorAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of apoptotic processAngiotensin-converting enzyme Homo sapiens (human)
peptide catabolic processAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of vasoconstrictionAngiotensin-converting enzyme Homo sapiens (human)
negative regulation of glucose importAngiotensin-converting enzyme Homo sapiens (human)
regulation of synaptic plasticityAngiotensin-converting enzyme Homo sapiens (human)
lung alveolus developmentAngiotensin-converting enzyme Homo sapiens (human)
amyloid-beta metabolic processAngiotensin-converting enzyme Homo sapiens (human)
arachidonic acid secretionAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of neurogenesisAngiotensin-converting enzyme Homo sapiens (human)
heart contractionAngiotensin-converting enzyme Homo sapiens (human)
regulation of angiotensin metabolic processAngiotensin-converting enzyme Homo sapiens (human)
hematopoietic stem cell differentiationAngiotensin-converting enzyme Homo sapiens (human)
angiogenesis involved in coronary vascular morphogenesisAngiotensin-converting enzyme Homo sapiens (human)
cellular response to glucose stimulusAngiotensin-converting enzyme Homo sapiens (human)
response to dexamethasoneAngiotensin-converting enzyme Homo sapiens (human)
cell proliferation in bone marrowAngiotensin-converting enzyme Homo sapiens (human)
regulation of heart rate by cardiac conductionAngiotensin-converting enzyme Homo sapiens (human)
negative regulation of calcium ion importAngiotensin-converting enzyme Homo sapiens (human)
response to thyroid hormoneAngiotensin-converting enzyme Homo sapiens (human)
blood vessel diameter maintenanceAngiotensin-converting enzyme Homo sapiens (human)
regulation of hematopoietic stem cell proliferationAngiotensin-converting enzyme Homo sapiens (human)
negative regulation of gap junction assemblyAngiotensin-converting enzyme Homo sapiens (human)
cellular response to aldosteroneAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of peptidyl-cysteine S-nitrosylationAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of systemic arterial blood pressureAngiotensin-converting enzyme Homo sapiens (human)
angiogenesisAminopeptidase NHomo sapiens (human)
cell differentiationAminopeptidase NHomo sapiens (human)
symbiont entry into host cellAminopeptidase NHomo sapiens (human)
proteolysisAminopeptidase NHomo sapiens (human)
peptide catabolic processAminopeptidase NHomo sapiens (human)
negative regulation of myotube differentiationHistone deacetylase 1Homo sapiens (human)
negative regulation of apoptotic processHistone deacetylase 1Homo sapiens (human)
positive regulation of signaling receptor activityHistone deacetylase 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone deacetylase 1Homo sapiens (human)
chromatin organizationHistone deacetylase 1Homo sapiens (human)
chromatin remodelingHistone deacetylase 1Homo sapiens (human)
DNA methylation-dependent heterochromatin formationHistone deacetylase 1Homo sapiens (human)
regulation of transcription by RNA polymerase IIHistone deacetylase 1Homo sapiens (human)
protein deacetylationHistone deacetylase 1Homo sapiens (human)
endoderm developmentHistone deacetylase 1Homo sapiens (human)
positive regulation of cell population proliferationHistone deacetylase 1Homo sapiens (human)
epidermal cell differentiationHistone deacetylase 1Homo sapiens (human)
positive regulation of gene expressionHistone deacetylase 1Homo sapiens (human)
negative regulation of gene expressionHistone deacetylase 1Homo sapiens (human)
hippocampus developmentHistone deacetylase 1Homo sapiens (human)
neuron differentiationHistone deacetylase 1Homo sapiens (human)
negative regulation of cell migrationHistone deacetylase 1Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayHistone deacetylase 1Homo sapiens (human)
circadian regulation of gene expressionHistone deacetylase 1Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusHistone deacetylase 1Homo sapiens (human)
odontogenesis of dentin-containing toothHistone deacetylase 1Homo sapiens (human)
regulation of cell fate specificationHistone deacetylase 1Homo sapiens (human)
embryonic digit morphogenesisHistone deacetylase 1Homo sapiens (human)
negative regulation of apoptotic processHistone deacetylase 1Homo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionHistone deacetylase 1Homo sapiens (human)
negative regulation by host of viral transcriptionHistone deacetylase 1Homo sapiens (human)
negative regulation of gene expression, epigeneticHistone deacetylase 1Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone deacetylase 1Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone deacetylase 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone deacetylase 1Homo sapiens (human)
positive regulation of smooth muscle cell proliferationHistone deacetylase 1Homo sapiens (human)
oligodendrocyte differentiationHistone deacetylase 1Homo sapiens (human)
positive regulation of oligodendrocyte differentiationHistone deacetylase 1Homo sapiens (human)
negative regulation of androgen receptor signaling pathwayHistone deacetylase 1Homo sapiens (human)
hair follicle placode formationHistone deacetylase 1Homo sapiens (human)
eyelid development in camera-type eyeHistone deacetylase 1Homo sapiens (human)
fungiform papilla formationHistone deacetylase 1Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayHistone deacetylase 1Homo sapiens (human)
negative regulation of stem cell population maintenanceHistone deacetylase 1Homo sapiens (human)
positive regulation of stem cell population maintenanceHistone deacetylase 1Homo sapiens (human)
regulation of stem cell differentiationHistone deacetylase 1Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayHistone deacetylase 1Homo sapiens (human)
heterochromatin formationHistone deacetylase 1Homo sapiens (human)
proteolysisMeprin A subunit betaHomo sapiens (human)
inflammatory responseMeprin A subunit betaHomo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
translationPeptide deformylase, mitochondrialHomo sapiens (human)
positive regulation of cell population proliferationPeptide deformylase, mitochondrialHomo sapiens (human)
peptidyl-methionine modificationPeptide deformylase, mitochondrialHomo sapiens (human)
N-terminal protein amino acid modificationPeptide deformylase, mitochondrialHomo sapiens (human)
co-translational protein modificationPeptide deformylase, mitochondrialHomo sapiens (human)
polyamine deacetylationHistone deacetylase 6Homo sapiens (human)
spermidine deacetylationHistone deacetylase 6Homo sapiens (human)
positive regulation of signaling receptor activityHistone deacetylase 6Homo sapiens (human)
protein polyubiquitinationHistone deacetylase 6Homo sapiens (human)
response to amphetamineHistone deacetylase 6Homo sapiens (human)
protein deacetylationHistone deacetylase 6Homo sapiens (human)
protein quality control for misfolded or incompletely synthesized proteinsHistone deacetylase 6Homo sapiens (human)
intracellular protein transportHistone deacetylase 6Homo sapiens (human)
autophagyHistone deacetylase 6Homo sapiens (human)
actin filament organizationHistone deacetylase 6Homo sapiens (human)
negative regulation of microtubule depolymerizationHistone deacetylase 6Homo sapiens (human)
regulation of autophagyHistone deacetylase 6Homo sapiens (human)
positive regulation of epithelial cell migrationHistone deacetylase 6Homo sapiens (human)
negative regulation of hydrogen peroxide metabolic processHistone deacetylase 6Homo sapiens (human)
regulation of macroautophagyHistone deacetylase 6Homo sapiens (human)
axonal transport of mitochondrionHistone deacetylase 6Homo sapiens (human)
negative regulation of protein-containing complex assemblyHistone deacetylase 6Homo sapiens (human)
regulation of protein stabilityHistone deacetylase 6Homo sapiens (human)
protein destabilizationHistone deacetylase 6Homo sapiens (human)
lysosome localizationHistone deacetylase 6Homo sapiens (human)
protein-containing complex disassemblyHistone deacetylase 6Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationHistone deacetylase 6Homo sapiens (human)
cellular response to heatHistone deacetylase 6Homo sapiens (human)
peptidyl-lysine deacetylationHistone deacetylase 6Homo sapiens (human)
response to immobilization stressHistone deacetylase 6Homo sapiens (human)
cellular response to topologically incorrect proteinHistone deacetylase 6Homo sapiens (human)
erythrocyte enucleationHistone deacetylase 6Homo sapiens (human)
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathwayHistone deacetylase 6Homo sapiens (human)
negative regulation of protein-containing complex disassemblyHistone deacetylase 6Homo sapiens (human)
regulation of fat cell differentiationHistone deacetylase 6Homo sapiens (human)
negative regulation of gene expression, epigeneticHistone deacetylase 6Homo sapiens (human)
negative regulation of proteolysisHistone deacetylase 6Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone deacetylase 6Homo sapiens (human)
collateral sproutingHistone deacetylase 6Homo sapiens (human)
negative regulation of axon extension involved in axon guidanceHistone deacetylase 6Homo sapiens (human)
positive regulation of dendrite morphogenesisHistone deacetylase 6Homo sapiens (human)
negative regulation of oxidoreductase activityHistone deacetylase 6Homo sapiens (human)
response to corticosteroneHistone deacetylase 6Homo sapiens (human)
response to misfolded proteinHistone deacetylase 6Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicHistone deacetylase 6Homo sapiens (human)
cilium assemblyHistone deacetylase 6Homo sapiens (human)
regulation of microtubule-based movementHistone deacetylase 6Homo sapiens (human)
regulation of androgen receptor signaling pathwayHistone deacetylase 6Homo sapiens (human)
dendritic spine morphogenesisHistone deacetylase 6Homo sapiens (human)
cilium disassemblyHistone deacetylase 6Homo sapiens (human)
parkin-mediated stimulation of mitophagy in response to mitochondrial depolarizationHistone deacetylase 6Homo sapiens (human)
regulation of establishment of protein localizationHistone deacetylase 6Homo sapiens (human)
cellular response to hydrogen peroxideHistone deacetylase 6Homo sapiens (human)
aggresome assemblyHistone deacetylase 6Homo sapiens (human)
polyubiquitinated misfolded protein transportHistone deacetylase 6Homo sapiens (human)
response to growth factorHistone deacetylase 6Homo sapiens (human)
cellular response to misfolded proteinHistone deacetylase 6Homo sapiens (human)
cellular response to parathyroid hormone stimulusHistone deacetylase 6Homo sapiens (human)
response to dexamethasoneHistone deacetylase 6Homo sapiens (human)
tubulin deacetylationHistone deacetylase 6Homo sapiens (human)
positive regulation of tubulin deacetylationHistone deacetylase 6Homo sapiens (human)
positive regulation of cellular response to oxidative stressHistone deacetylase 6Homo sapiens (human)
negative regulation of protein acetylationHistone deacetylase 6Homo sapiens (human)
regulation of autophagy of mitochondrionHistone deacetylase 6Homo sapiens (human)
positive regulation of cholangiocyte proliferationHistone deacetylase 6Homo sapiens (human)
negative regulation of aggrephagyHistone deacetylase 6Homo sapiens (human)
epigenetic regulation of gene expressionHistone deacetylase 6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (67)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityUrokinase-type plasminogen activatorHomo sapiens (human)
protein bindingUrokinase-type plasminogen activatorHomo sapiens (human)
endopeptidase activityInterstitial collagenaseHomo sapiens (human)
metalloendopeptidase activityInterstitial collagenaseHomo sapiens (human)
serine-type endopeptidase activityInterstitial collagenaseHomo sapiens (human)
peptidase activityInterstitial collagenaseHomo sapiens (human)
zinc ion bindingInterstitial collagenaseHomo sapiens (human)
fibronectin binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
metalloendopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
serine-type endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
protein binding72 kDa type IV collagenaseHomo sapiens (human)
metallopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
zinc ion binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activityStromelysin-1Homo sapiens (human)
metalloendopeptidase activityStromelysin-1Homo sapiens (human)
serine-type endopeptidase activityStromelysin-1Homo sapiens (human)
protein bindingStromelysin-1Homo sapiens (human)
peptidase activityStromelysin-1Homo sapiens (human)
metallopeptidase activityStromelysin-1Homo sapiens (human)
zinc ion bindingStromelysin-1Homo sapiens (human)
phosphatidylserine bindingNeprilysinHomo sapiens (human)
endopeptidase activityNeprilysinHomo sapiens (human)
metalloendopeptidase activityNeprilysinHomo sapiens (human)
protein bindingNeprilysinHomo sapiens (human)
exopeptidase activityNeprilysinHomo sapiens (human)
zinc ion bindingNeprilysinHomo sapiens (human)
peptide bindingNeprilysinHomo sapiens (human)
protein homodimerization activityNeprilysinHomo sapiens (human)
oligopeptidase activityNeprilysinHomo sapiens (human)
cardiolipin bindingNeprilysinHomo sapiens (human)
endopeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
carboxypeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
metalloendopeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
calmodulin bindingAngiotensin-converting enzyme Homo sapiens (human)
peptidase activityAngiotensin-converting enzyme Homo sapiens (human)
metallopeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
exopeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
tripeptidyl-peptidase activityAngiotensin-converting enzyme Homo sapiens (human)
peptidyl-dipeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
zinc ion bindingAngiotensin-converting enzyme Homo sapiens (human)
chloride ion bindingAngiotensin-converting enzyme Homo sapiens (human)
mitogen-activated protein kinase kinase bindingAngiotensin-converting enzyme Homo sapiens (human)
bradykinin receptor bindingAngiotensin-converting enzyme Homo sapiens (human)
mitogen-activated protein kinase bindingAngiotensin-converting enzyme Homo sapiens (human)
metallodipeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
heterocyclic compound bindingAngiotensin-converting enzyme Homo sapiens (human)
virus receptor activityAminopeptidase NHomo sapiens (human)
aminopeptidase activityAminopeptidase NHomo sapiens (human)
metallopeptidase activityAminopeptidase NHomo sapiens (human)
signaling receptor activityAminopeptidase NHomo sapiens (human)
metalloaminopeptidase activityAminopeptidase NHomo sapiens (human)
zinc ion bindingAminopeptidase NHomo sapiens (human)
peptide bindingAminopeptidase NHomo sapiens (human)
nucleosomal DNA bindingHistone deacetylase 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingHistone deacetylase 1Homo sapiens (human)
RNA polymerase II core promoter sequence-specific DNA bindingHistone deacetylase 1Homo sapiens (human)
core promoter sequence-specific DNA bindingHistone deacetylase 1Homo sapiens (human)
transcription corepressor bindingHistone deacetylase 1Homo sapiens (human)
p53 bindingHistone deacetylase 1Homo sapiens (human)
transcription corepressor activityHistone deacetylase 1Homo sapiens (human)
histone deacetylase activityHistone deacetylase 1Homo sapiens (human)
protein bindingHistone deacetylase 1Homo sapiens (human)
enzyme bindingHistone deacetylase 1Homo sapiens (human)
protein lysine deacetylase activityHistone deacetylase 1Homo sapiens (human)
Krueppel-associated box domain bindingHistone deacetylase 1Homo sapiens (human)
histone deacetylase bindingHistone deacetylase 1Homo sapiens (human)
NF-kappaB bindingHistone deacetylase 1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHistone deacetylase 1Homo sapiens (human)
E-box bindingHistone deacetylase 1Homo sapiens (human)
DNA-binding transcription factor bindingHistone deacetylase 1Homo sapiens (human)
histone decrotonylase activityHistone deacetylase 1Homo sapiens (human)
promoter-specific chromatin bindingHistone deacetylase 1Homo sapiens (human)
protein bindingMeprin A subunit betaHomo sapiens (human)
zinc ion bindingMeprin A subunit betaHomo sapiens (human)
identical protein bindingMeprin A subunit betaHomo sapiens (human)
metalloendopeptidase activityMeprin A subunit betaHomo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
peptide deformylase activityPeptide deformylase, mitochondrialHomo sapiens (human)
metal ion bindingPeptide deformylase, mitochondrialHomo sapiens (human)
acetylspermidine deacetylase activityHistone deacetylase 6Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingHistone deacetylase 6Homo sapiens (human)
transcription corepressor bindingHistone deacetylase 6Homo sapiens (human)
actin bindingHistone deacetylase 6Homo sapiens (human)
histone deacetylase activityHistone deacetylase 6Homo sapiens (human)
protein bindingHistone deacetylase 6Homo sapiens (human)
beta-catenin bindingHistone deacetylase 6Homo sapiens (human)
microtubule bindingHistone deacetylase 6Homo sapiens (human)
zinc ion bindingHistone deacetylase 6Homo sapiens (human)
enzyme bindingHistone deacetylase 6Homo sapiens (human)
polyubiquitin modification-dependent protein bindingHistone deacetylase 6Homo sapiens (human)
ubiquitin protein ligase bindingHistone deacetylase 6Homo sapiens (human)
protein lysine deacetylase activityHistone deacetylase 6Homo sapiens (human)
histone deacetylase bindingHistone deacetylase 6Homo sapiens (human)
tubulin deacetylase activityHistone deacetylase 6Homo sapiens (human)
alpha-tubulin bindingHistone deacetylase 6Homo sapiens (human)
ubiquitin bindingHistone deacetylase 6Homo sapiens (human)
tau protein bindingHistone deacetylase 6Homo sapiens (human)
beta-tubulin bindingHistone deacetylase 6Homo sapiens (human)
misfolded protein bindingHistone deacetylase 6Homo sapiens (human)
Hsp90 protein bindingHistone deacetylase 6Homo sapiens (human)
dynein complex bindingHistone deacetylase 6Homo sapiens (human)
transcription factor bindingHistone deacetylase 6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (64)

Processvia Protein(s)Taxonomy
extracellular regionUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
focal adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
external side of plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
cell surfaceUrokinase-type plasminogen activatorHomo sapiens (human)
specific granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular exosomeUrokinase-type plasminogen activatorHomo sapiens (human)
tertiary granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexUrokinase-type plasminogen activatorHomo sapiens (human)
protein complex involved in cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
serine-type endopeptidase complexUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular regionInterstitial collagenaseHomo sapiens (human)
extracellular matrixInterstitial collagenaseHomo sapiens (human)
extracellular spaceInterstitial collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular region72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
nucleus72 kDa type IV collagenaseHomo sapiens (human)
mitochondrion72 kDa type IV collagenaseHomo sapiens (human)
plasma membrane72 kDa type IV collagenaseHomo sapiens (human)
sarcomere72 kDa type IV collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
extracellular regionStromelysin-1Homo sapiens (human)
nucleusStromelysin-1Homo sapiens (human)
mitochondrionStromelysin-1Homo sapiens (human)
cytosolStromelysin-1Homo sapiens (human)
extracellular matrixStromelysin-1Homo sapiens (human)
extracellular spaceStromelysin-1Homo sapiens (human)
cytoplasmNeprilysinHomo sapiens (human)
early endosomeNeprilysinHomo sapiens (human)
trans-Golgi networkNeprilysinHomo sapiens (human)
plasma membraneNeprilysinHomo sapiens (human)
brush borderNeprilysinHomo sapiens (human)
focal adhesionNeprilysinHomo sapiens (human)
synaptic vesicleNeprilysinHomo sapiens (human)
cell surfaceNeprilysinHomo sapiens (human)
membraneNeprilysinHomo sapiens (human)
axonNeprilysinHomo sapiens (human)
dendriteNeprilysinHomo sapiens (human)
secretory granule membraneNeprilysinHomo sapiens (human)
cytoplasmic vesicleNeprilysinHomo sapiens (human)
neuronal cell bodyNeprilysinHomo sapiens (human)
neuron projection terminusNeprilysinHomo sapiens (human)
membrane raftNeprilysinHomo sapiens (human)
synapseNeprilysinHomo sapiens (human)
extracellular exosomeNeprilysinHomo sapiens (human)
presynapseNeprilysinHomo sapiens (human)
plasma membraneNeprilysinHomo sapiens (human)
extracellular spaceAngiotensin-converting enzyme Homo sapiens (human)
extracellular regionAngiotensin-converting enzyme Homo sapiens (human)
extracellular spaceAngiotensin-converting enzyme Homo sapiens (human)
lysosomeAngiotensin-converting enzyme Homo sapiens (human)
endosomeAngiotensin-converting enzyme Homo sapiens (human)
plasma membraneAngiotensin-converting enzyme Homo sapiens (human)
external side of plasma membraneAngiotensin-converting enzyme Homo sapiens (human)
basal plasma membraneAngiotensin-converting enzyme Homo sapiens (human)
brush border membraneAngiotensin-converting enzyme Homo sapiens (human)
extracellular exosomeAngiotensin-converting enzyme Homo sapiens (human)
sperm midpieceAngiotensin-converting enzyme Homo sapiens (human)
plasma membraneAngiotensin-converting enzyme Homo sapiens (human)
extracellular spaceAminopeptidase NHomo sapiens (human)
lysosomal membraneAminopeptidase NHomo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentAminopeptidase NHomo sapiens (human)
plasma membraneAminopeptidase NHomo sapiens (human)
external side of plasma membraneAminopeptidase NHomo sapiens (human)
secretory granule membraneAminopeptidase NHomo sapiens (human)
extracellular exosomeAminopeptidase NHomo sapiens (human)
cytoplasmAminopeptidase NHomo sapiens (human)
plasma membraneAminopeptidase NHomo sapiens (human)
extracellular spaceAminopeptidase NHomo sapiens (human)
nucleusHistone deacetylase 1Homo sapiens (human)
nucleoplasmHistone deacetylase 1Homo sapiens (human)
cytoplasmHistone deacetylase 1Homo sapiens (human)
cytosolHistone deacetylase 1Homo sapiens (human)
NuRD complexHistone deacetylase 1Homo sapiens (human)
neuronal cell bodyHistone deacetylase 1Homo sapiens (human)
Sin3-type complexHistone deacetylase 1Homo sapiens (human)
histone deacetylase complexHistone deacetylase 1Homo sapiens (human)
chromatinHistone deacetylase 1Homo sapiens (human)
heterochromatinHistone deacetylase 1Homo sapiens (human)
transcription repressor complexHistone deacetylase 1Homo sapiens (human)
protein-containing complexHistone deacetylase 1Homo sapiens (human)
nucleusHistone deacetylase 1Homo sapiens (human)
extracellular regionMeprin A subunit betaHomo sapiens (human)
plasma membraneMeprin A subunit betaHomo sapiens (human)
meprin A complexMeprin A subunit betaHomo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
mitochondrionPeptide deformylase, mitochondrialHomo sapiens (human)
mitochondrionPeptide deformylase, mitochondrialHomo sapiens (human)
nucleusHistone deacetylase 6Homo sapiens (human)
nucleoplasmHistone deacetylase 6Homo sapiens (human)
cytoplasmHistone deacetylase 6Homo sapiens (human)
multivesicular bodyHistone deacetylase 6Homo sapiens (human)
centrosomeHistone deacetylase 6Homo sapiens (human)
cytosolHistone deacetylase 6Homo sapiens (human)
microtubuleHistone deacetylase 6Homo sapiens (human)
caveolaHistone deacetylase 6Homo sapiens (human)
inclusion bodyHistone deacetylase 6Homo sapiens (human)
aggresomeHistone deacetylase 6Homo sapiens (human)
axonHistone deacetylase 6Homo sapiens (human)
dendriteHistone deacetylase 6Homo sapiens (human)
cell leading edgeHistone deacetylase 6Homo sapiens (human)
ciliary basal bodyHistone deacetylase 6Homo sapiens (human)
perikaryonHistone deacetylase 6Homo sapiens (human)
perinuclear region of cytoplasmHistone deacetylase 6Homo sapiens (human)
axon cytoplasmHistone deacetylase 6Homo sapiens (human)
histone deacetylase complexHistone deacetylase 6Homo sapiens (human)
microtubule associated complexHistone deacetylase 6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (174)

Assay IDTitleYearJournalArticle
AID572912Antimicrobial activity against Bacillus subtilis harboring fmt G118D mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID38855Compound was tested for its inhibitory activity against Angiotensin I converting enzyme2001Bioorganic & medicinal chemistry letters, Oct-08, Volume: 11, Issue:19
Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
AID1890851Cytotoxicity against mouse BMDM cells2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID1658891Inhibition of HDAC6 (unknown origin) using Boc-Lys(Ac)-pNA as substrate preincubated for 20 mins followed by substrate addition and further incubated for 90 mins by fluorescence assay2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID68047In vitro antibacterial activity against Enterococcus faecalis ATCC 29212.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID66108In vitro antibacterial activity against Enterococcus faecium vanA E25_1.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID207360In vitro minimum inhibitory concentration required against Staphylococcus aureus ATCC 103902003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives.
AID1890836Antimycobacterial activity against Mycobacterium abscessus CIP104536T with smooth morphotype assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID572911Antimicrobial activity against Bacillus subtilis harboring fmt R116P mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID655295Antibacterial activity against Staphylococcus aureus RN4220 after 18 hrs by broth microdilution method2012Journal of natural products, Feb-24, Volume: 75, Issue:2
Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes.
AID275208Antibacterial activity against Escherichia coli CAG12842007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID157063In vitro inhibitory concentration required against peptide deformylase (PDF)2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives.
AID275212Antibacterial activity against Bacillus subtilis MO34822007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID572905Antimicrobial activity against Bacillus subtilis harboring fmt with base pair insertion at position 745 after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID1890846Selectivity index, ratio of MIC90 for antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC empty vector to MIC90 for antimycobacterial activity against wild type Mycobacterium smegmatis mc2 1552022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID40941In vitro antibacterial activity against Bacillus subtilis ATCC 585969.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID572902Antimicrobial activity against Bacillus subtilis harboring fmt with 295 to 639 base pair deletion mutation after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID56211Inhibitory activity against dipeptidyl peptidase IV (DPP- IV)1998Journal of medicinal chemistry, Jan-29, Volume: 41, Issue:3
Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton.
AID609154Antibacterial activity against Citrobacter freundii ATCC 80902011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID156922Antibacterial activity against Escherichia coli Peptide deformylase. Ni2001Bioorganic & medicinal chemistry letters, Oct-08, Volume: 11, Issue:19
Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
AID1890848Selectivity index, ratio of MIC90 for antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC::PDFMtb overexpression mutant to MIC90 for antimycobacterial activity against wild type Mycobacterium smegmatis mc2 1552022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID1096866Inhibition of APM (unknown origin) assessed as inhibition of endomorphin-1 degradation after 30 min2012Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, Jul, Volume: 21, Issue:7
Kinetic studies of novel inhibitors of endomorphin degrading enzymes.
AID1890842Antimycobacterial activity against wild type Mycobacterium smegmatis mc2 155 assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID609244Cytotoxicity against human HL60 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID147394The compound was evaluated in vitro for the inhibition of Neutral endopeptidase2001Bioorganic & medicinal chemistry letters, Oct-08, Volume: 11, Issue:19
Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
AID70616In vitro antibacterial activity against Escherichia coli ATCC 25922.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID1658886Induction of apoptosis in human A549 cells assessed as late apoptotic cells at 40 uM measured after 48 hrs by Annexin V-FITC/propidium iodide staining based FACSClibur flow cytometry analysis (Rvb = 3.63 %)2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID275204Inhibition of PDF22007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID655294Inhibition of Staphylococcus aureus peptide deformylase using N-formylmethionine-alanine-serine as substrate by spectrophotometry2012Journal of natural products, Feb-24, Volume: 75, Issue:2
Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes.
AID70639In vitro antibacterial activity against isolated Escherichia coli DC22000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID1658889Inhibition of HDAC1 (unknown origin) using Boc-Lys(Ac)-pNA as substrate preincubated for 20 mins followed by substrate addition and further incubated for 90 mins by fluorescence assay2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID1890839Antimycobacterial activity against Mycobacterium tuberculosis mc2 6230 assessed as inhibition of mycobacterial growth incubated for 10 to 14 days by resazurin microtiter assay2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID157321Inhibitory activity against isolated Escherichia coli peptidyl deformylase (PDF) enzyme containing iron.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID524791Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1658890Inhibition of HDAC1 (unknown origin) at 10 uM using Boc-Lys(Ac)-pNA as substrate preincubated for 20 mins followed by substrate addition and further incubated for 90 mins by fluorescence assay relative to control2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID572908Antimicrobial activity against Bacillus subtilis harboring fmt S110P mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID609249Cytotoxicity against human CWR22 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID609243Antifungal activity against Candida albicans ATCC 900282011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1096867Inhibition of APM (unknown origin) assessed as half-life of endomorphin-1 after 30 min by RP-HPLC analysis (Rvb = 19.7 +/- 0.5 min)2012Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, Jul, Volume: 21, Issue:7
Kinetic studies of novel inhibitors of endomorphin degrading enzymes.
AID282339Inhibition of soybean PDF using PDF/FDH coupled spectrophotometric assay2004Journal of medicinal chemistry, Dec-30, Volume: 47, Issue:27
A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening.
AID609242Antibacterial activity against Bacteroides fragilis ATCC 252852011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID524795Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID572914Antimicrobial activity against Bacillus subtilis harboring folD S71Q, S72Q and L73P mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID1658884Induction of apoptosis in human A549 cells assessed as live cells at 40 uM measured after 48 hrs by Annexin V-FITC/propidium iodide staining based FACSClibur flow cytometry analysis (Rvb = 95.5 %)2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID1658888Induction of apoptosis in human A549 cells assessed as induction of caspase-3 activation at 40 uM using Ac-DEVD-pNA as substrate preincubated for 24 hrs followed by substrate addition and measured after 2 hrs by microplate reader assay2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID275203Inhibition of PDF1B2007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID609145Inhibition of porcine kidney microsomal aminopeptidase N at 100 uM after 1 hr by fluorescence polarization based competition assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1658870Antiproliferative activity against human HCT116 cells assessed as reduction in cell growth measured after 48 hrs by CCK8 assay2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID1658881Induction of apoptosis in human A549 cells assessed as early apoptotic cells at 40 uM measured after 24 hrs by Annexin V-FITC/propidium iodide staining based FACSClibur flow cytometry analysis (Rvb = 0.35 %)2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID609245Cytotoxicity against human vincristine-resistant HL60 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1658883Induction of apoptosis in human A549 cells assessed as necrotic cells at 40 uM measured after 24 hrs by Annexin V-FITC/propidium iodide staining based FACSClibur flow cytometry analysis (Rvb = 0.37 %)2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID609148Antibacterial activity against Staphylococcus epidermidis ATCC 122282011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID609155Antibacterial activity against Enterobacter cloacae ATCC 130472011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID275209Antibacterial activity against Bacillus subtilis 1682007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID609250Cytotoxicity against human HEK293 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID609140Inhibition of human peptide deformylase after 1 hr by fluorescence polarization based competition assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1890837Antimycobacterial activity against Mycobacterium abscessus CIP104536T with rough morphotype assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID275211Antibacterial activity against Bacillus subtilis Y1012007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID162784In vitro minimum inhibitory concentration required against Pseudomonas aeruginosa ATCC 90272003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives.
AID1890843Antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC empty vector assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID275202Inhibition of Arabidopsis thaliana mitochondrial PDF1A2007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID279574Antimicrobial activity against Salmonella enterica serovar Typhimurium DA8326 in Caenorhabditis elegans2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.
AID748610Antibacterial activity against multidrug-resistant Enterobacter aerogenes EA289 overexpressing AcrAB-tolC assessed as growth inhibition after 18 hrs by two-fold serial dilution method2013ACS medicinal chemistry letters, Jun-13, Volume: 4, Issue:6
New Peptide-based antimicrobials for tackling drug resistance in bacteria: single-cell fluorescence imaging.
AID147706Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureus2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
Identification of novel potent bicyclic peptide deformylase inhibitors.
AID655296Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 18 hrs by broth microdilution method2012Journal of natural products, Feb-24, Volume: 75, Issue:2
Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes.
AID1890844Antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC::PDFMtb overexpression mutant assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID524790Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID609241Antibacterial activity against Propionibacterium acnes ATCC 118272011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID302848Inhibition of thermolysin by enzcheck protease assay2007Bioorganic & medicinal chemistry letters, Dec-01, Volume: 17, Issue:23
Identifying common metalloprotease inhibitors by protein fold types using Fourier transform mass spectrometry.
AID1380363Competitive inhibition of aminopeptidase-M (unknown origin)2018Journal of medicinal chemistry, Aug-09, Volume: 61, Issue:15
Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.
AID572915Antimicrobial activity against Bacillus subtilis harboring folD E17Q mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID609246Cytotoxicity against human Jurkat cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1658879Inhibition of PDF in human MCF7 cells assessed as decrease in mtDNA encoded COX1 protein level at 40 uM measured after 48 hrs by Western blot analysis2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID157064Binding affinity towards Peptide deformylase2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives.
AID1658882Induction of apoptosis in human A549 cells assessed as late apoptotic cells at 40 uM measured after 24 hrs by Annexin V-FITC/propidium iodide staining based FACSClibur flow cytometry analysis (Rvb = 2.32 %)2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID275201Inhibition of human mitochondrial PDF2007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID1450126Inhibition of human meprin beta expressed in baculovirus infected BTI-TN-5B1-4 insect cells using N-benzoyl-L-tyrosylp-aminobenzoic acid as substrate2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
First insight into structure-activity relationships of selective meprin β inhibitors.
AID572907Antimicrobial activity against Bacillus subtilis harboring fmt H108R mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID207418In vitro antibacterial activity against Staphylococcus aureus ATCC 25923.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID655297Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 18 hrs by broth microdilution method2012Journal of natural products, Feb-24, Volume: 75, Issue:2
Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes.
AID208782In vitro antibacterial activity against Streptococcus pneumoniae 1/1 (penicillin resistant).2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID609143Inhibition of Escherichia coli peptide deformylase at 100 uM after 1 hr by fluorescence polarization based competition assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1096864Inhibition of APM (unknown origin) assessed as inhibition of endomorphin-2 degradation after 30 min2012Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, Jul, Volume: 21, Issue:7
Kinetic studies of novel inhibitors of endomorphin degrading enzymes.
AID275207Antibacterial activity against Escherichia coli K372007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID1375470Inhibition of recombinant human meprin beta expressed in baculovirus infected insect cells using N-benzoyl-L-tyrosyl-p-aminobenzoic acid as substrate2018Journal of medicinal chemistry, 05-24, Volume: 61, Issue:10
Structure-Guided Design, Synthesis, and Characterization of Next-Generation Meprin β Inhibitors.
AID143567In vitro antibacterial activity against Mycoplasma pneumoniae ATCC 29342.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID208792In vitro antibacterial activity against Streptococcus pneumoniae ATCC 49619.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID83799In vitro antibacterial activity against Haemophilus influenzae 11.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID572903Antimicrobial activity against Bacillus subtilis harboring fmt with deletion mutation at base pair 745 after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID52112In vitro antibacterial activity against Chlamydia pneumoniae AR-39.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID609251Cytotoxicity against human Y79 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID572917Antimicrobial activity against Bacillus subtilis harboring glyA with deletion mutation of base pair 661 to 663 after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID275205Antibacterial activity against Escherichia coli JM101Tr2007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID275210Antibacterial activity against Bacillus subtilis D1012007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID609152Antibacterial activity against Streptococcus pneumoniae ATCC 63012011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1658885Induction of apoptosis in human A549 cells assessed as early apoptotic cells at 40 uM measured after 48 hrs by Annexin V-FITC/propidium iodide staining based FACSClibur flow cytometry analysis (Rvb = 0.40 %)2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID524793Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID572904Antimicrobial activity against Bacillus subtilis harboring fmt with deletion mutation at base pair 119 after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID609153Antibacterial activity against Haemophilus influenzae ATCC 497662011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID67194Inhibitory activity against human bronchiolar smooth muscle Endothelin-converting enzyme 11995Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
Hydroxamic acids as potent inhibitors of endothelin-converting enzyme from human bronchiolar smooth muscle.
AID68862In vitro minimum inhibitory concentration required against Escherichia coli ATCC 259222003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives.
AID1890847Selectivity index, ratio of MIC50 for antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC::PDFMtb overexpression mutant to MIC50 for antimycobacterial activity against wild type Mycobacterium smegmatis mc2 1552022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID107671Inhibition of Matrix metalloprotease-32001Bioorganic & medicinal chemistry letters, Oct-08, Volume: 11, Issue:19
Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
AID572906Antimicrobial activity against Bacillus subtilis harboring fmt AGA to TGA and R3stop mutation after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID107844Inhibition of Matrix metalloprotease-72001Bioorganic & medicinal chemistry letters, Oct-08, Volume: 11, Issue:19
Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
AID279575Antimicrobial activity against Salmonella enterica serovar Typhimurium DA8340 in Caenorhabditis elegans2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.
AID609151Antibacterial activity against Enterococcus faecium ATCC 194342011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1658878Inhibition of PDF in human A549 cells assessed as decrease in mtDNA encoded COX1 protein level at 40 uM measured after 48 hrs by Western blot analysis2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID163952In vitro antibacterial activity against Pseudomonas aeruginosa ATCC 27853.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID609156Antibacterial activity against Escherichia coli ATCC 259222011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID275206Antibacterial activity against Bacillus subtilis2007Journal of medicinal chemistry, Jan-11, Volume: 50, Issue:1
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
AID1658868Inhibition of human PDF using N-formylated peptide as substrate in presence of NAD+ by formate dehydrogenase-coupled spectrophotometric assay2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID609248Cytotoxicity against human ALL3 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID207132In vitro antibacterial activity against Stenotrophomonas maltophilia 1AC739.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID609149Antibacterial activity against Streptococcus pyogenes ATCC 196152011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1658869Inhibition of human PDF expressed in Escherichia coli BL21 pLysS using formyl-Met-Ala-His-Ala peptide as substrate measured after 1 hr by fluorescamine-based fluorescence assay2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID609146Inhibition of human recombinant MMP1 at 100 uM after 1 hr by fluorescence polarization based competition assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID609142Inhibition of human peptide deformylase at 100 uM after 1 hr by fluorescence polarization based competition assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID609247Cytotoxicity against human MOLT3 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID572909Antimicrobial activity against Bacillus subtilis harboring fmt P113L mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID1096865Inhibition of APM (unknown origin) assessed as half-life of endomorphin-2 after 30 min by RP-HPLC analysis (Rvb = 23.3 +/- 0.98 min)2012Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, Jul, Volume: 21, Issue:7
Kinetic studies of novel inhibitors of endomorphin degrading enzymes.
AID609150Antibacterial activity against Enterococcus faecalis ATCC 292122011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1890841Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 8 days2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID748609Antibacterial activity against tolC-deficient Enterobacter aerogenes EA298 assessed as growth inhibition after 18 hrs by two-fold serial dilution method2013ACS medicinal chemistry letters, Jun-13, Volume: 4, Issue:6
New Peptide-based antimicrobials for tackling drug resistance in bacteria: single-cell fluorescence imaging.
AID609252Cytotoxicity against human Meso47 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID524794Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID524792Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID572910Antimicrobial activity against Bacillus subtilis harboring fmt R116C mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID125113In vitro antibacterial activity against isolated Moraxella catarrhalis RA212000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
AID1890850Inhibition of Mycobacterium tuberculosis H37Rv PDF expressed in Escherichia coli using N-formyl-methionine-alanine-serine as substrate incubated for 2.5 mins by fluorescence based microplate reader analysis2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID572913Antimicrobial activity against Bacillus subtilis harboring fmt P120L mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID748611Antibacterial activity against acrAB-deficient Escherichia coli AG100A assessed as growth inhibition after 18 hrs by two-fold serial dilution method2013ACS medicinal chemistry letters, Jun-13, Volume: 4, Issue:6
New Peptide-based antimicrobials for tackling drug resistance in bacteria: single-cell fluorescence imaging.
AID609144Inhibition of Escherichia coli peptide deformylase using fMAHA as substrate after 1 hr by FLUO assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID572916Antimicrobial activity against Bacillus subtilis harboring folD T184M mutant after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID1890838Antimycobacterial activity against Mycobacterium marinum ATCC BAA-535/M assessed as inhibition of mycobacterial growth incubated for 10 to 14 days by resazurin microtiter assay2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID279573Antimicrobial activity against Salmonella enterica serovar Typhimurium DA8325 in Caenorhabditis elegans2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.
AID572918Antimicrobial activity against Bacillus subtilis harboring folD with deletion mutation of base pair 507 to 518 after 17 hrs by microtiter broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
AID107329Inhibition of Matrix metalloprotease-22001Bioorganic & medicinal chemistry letters, Oct-08, Volume: 11, Issue:19
Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
AID1658887Induction of apoptosis in human A549 cells assessed as necrotic cells at 40 uM measured after 48 hrs by Annexin V-FITC/propidium iodide staining based FACSClibur flow cytometry analysis (Rvb = 0.49 %)2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID147213Inhibitory activity against big ET-1 of Neutral endopeptidase1995Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
Hydroxamic acids as potent inhibitors of endothelin-converting enzyme from human bronchiolar smooth muscle.
AID1658892Inhibition of HDAC6 (unknown origin) at 10 uM using Boc-Lys(Ac)-pNA as substrate preincubated for 20 mins followed by substrate addition and further incubated for 90 mins by fluorescence assay relative to control2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID1658880Induction of apoptosis in human A549 cells assessed as live cells at 40 uM measured after 24 hrs by Annexin V-FITC/propidium iodide staining based FACSClibur flow cytometry analysis (Rvb = 97 %)2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
AID524796Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1890845Selectivity index, ratio of MIC50 for antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC empty vector to MIC50 for antimycobacterial activity against wild type Mycobacterium smegmatis mc2 1552022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
AID109226Inhibition of human Matrix metalloprotease-12001Bioorganic & medicinal chemistry letters, Oct-08, Volume: 11, Issue:19
Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
AID38377Inhibitory activity against aminopeptidase N assayed by the L-Ala-MCA method.1998Journal of medicinal chemistry, Jan-29, Volume: 41, Issue:3
Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton.
AID748612Antibacterial activity against wild type Escherichia coli AG100 assessed as growth inhibition after 18 hrs by two-fold serial dilution method2013ACS medicinal chemistry letters, Jun-13, Volume: 4, Issue:6
New Peptide-based antimicrobials for tackling drug resistance in bacteria: single-cell fluorescence imaging.
AID609147Antibacterial activity against Staphylococcus aureus ATCC 292132011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2011PLoS biology, May, Volume: 9, Issue:5
Trapping conformational states along ligand-binding dynamics of peptide deformylase: the impact of induced fit on enzyme catalysis.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2013The ISME journal, Jun, Volume: 7, Issue:6
Structure and function of a cyanophage-encoded peptide deformylase.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2014Acta crystallographica. Section D, Biological crystallography, Feb, Volume: 70, Issue:Pt 2
Understanding the highly efficient catalysis of prokaryotic peptide deformylases by shedding light on the determinants specifying the low activity of the human counterpart.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (163)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (4.91)18.7374
1990's14 (8.59)18.2507
2000's77 (47.24)29.6817
2010's49 (30.06)24.3611
2020's15 (9.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.37 (24.57)
Research Supply Index5.12 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index39.83 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.20%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other164 (98.80%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]